• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    BD Recalls Intraosseous Products Over Multiple Issues

    Rapid Medical Expands U.S. Portfolio

    MMS Holdings Partners With Lindsay Goldberg

    ENDRA Life Sciences Issued 28th Patent

    Levita Magnetics Closes $26M Series C
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cooling and Melting the Pain Away

    What Are the Fundamentals of Go-To-Market Strategy in Medical Devices?

    Minding the Gap: How Harmonizing Quality Systems Pays Off

    Building Strong Partnerships Between Medtech and Surgeon-Learning Platforms

    Four Key Considerations for OEMs Transferring a Product Program
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    JBC Technologies

    BMP Medical

    Concise Engineering

    Cirtec Medical

    Arthur G. Russell Co. Inc., The
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Medical Computing: COM Express Processes Real-Time Data at the Edge

    The Importance of Building Successful Supplier Relationships

    The Benefits of Outsourcing Innovation in Medtech Manufacturing

    Patching Healthcare Cybersecurity Risks in the Internet of Medical Things

    Leveraging Open Healthcare Data Standards to Improve Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    JBC Technologies

    BMP Medical

    Concise Engineering

    Cirtec Medical

    Arthur G. Russell Co. Inc., The
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Quality Assurance When Supply Chain Disruptions Arise

    From supply chain disruptions to impromptu manufacturing modifications, the medical device industry has faced a whirlwind of complications in 2020.

    Related CONTENT
    • Auriga Inc.
    • WESTPAK, Inc.
    • BMP Medical - Delivering Custom Plastics Manufactured Solutions
    • Simbex
    • DDL Inc.
    Sandi Schaible and Peter Steen, WuXi AppTec Medical Device Testing11.04.20
    From supply chain disruptions to impromptu manufacturing modifications, the medical device industry has faced a whirlwind of complications in 2020. While many in the industry are working in overdrive to keep projects on track, the regulatory landscape can shift day-to-day, making it challenging to keep up with best practices for gaining or maintaining regulatory approval. To avoid setbacks with compliance, medical device manufacturers should strive to anticipate potential challenges and institute proactive measures.

    Companies can begin to identify where a device may face risks by first looking into the sources that can cause complications and delays. Changes to device design, the manufacturing process, or the supply chain can present challenges when seeking regulatory approval. To achieve the highest level of quality assurance, companies should dedicate time to identifying each obstacle and develop precautions to stay ahead of any increases in risk.

    Managing Material Needs
    Backlogged supply deliveries in the past year have led to a widespread desire to move to onshore sourcing. From decreased capacity to transportation slowdowns, the limited availability of certain materials has made it difficult to maintain adequate supplies for production. These challenges, paired with the increasing scrutiny of materials with the publication of ISO 10993-18:2020, can create obstacles for device manufacturers trying to protect the quality, performance, and safety of their products during development and beyond.

    Before material needs escalate, companies should consider a proactive approach to maintaining production. They can start by evaluating the risks of adding more safety stock compared to the likelihood of future shortages. If expanding safety stock presents fewer risks and is actionable financially, this should be a manufacturer’s primary step to managing future material needs. This is an especially important step for small to mid-sized manufacturers that might face increased challenges in purchasing due to their comparative lack of scale.

    If safety stock doesn’t resolve issues with material sourcing, companies can brainstorm creative uses for work-in-progress materials. Utilizing what is available in unique ways could yield additional time to investigate future solutions more thoroughly. For example, if the same material is used across multiple products, discontinuing the manufacturing of a less profitable or in-demand product can allow for materials to be used for more critical devices.

    Additionally, working with materials that have an established history in the device’s production process can reduce new variables of risk. In general, companies should encourage the use of proven materials with a history of testing with labs and regulatory bodies whenever possible. Novel materials may be at higher risk of scrutiny and unsatisfactory outcomes among regulators in risk assessments, where proven materials help minimize the likelihood of these setbacks.

    Ensuring Production Quality
    Whether scaling up, down, or maintaining production, most manufacturers have had to ask themselves tough questions about how best to utilize their investments and facilities, both now and in the long term. Not only is there interest in switching to domestic suppliers, but there’s also interest in the strategy of moving manufacturing sites onshore. Taking a more measured approach can help ensure the quality from development through the entire product lifecycle.

    Evaluating the production process starts with a risk analysis to determine if changes will require additional testing. Changes to manufacturing, such as moving locations or changing cleaning agents, cannot be overlooked—no matter how seemingly insignificant they are. Identifying the risks associated with these changes before implementing them provides an opportunity to involve the right parties ahead of time to address necessary compliance precautions and avoid over-testing.

    Capacity constraints aren’t limited to manufacturers but can extend beyond the supply chain to testing labs. For example, it’s possible that testing labs won’t have the ability to be as responsive to requests for quick turnaround times as they have in the past. Particularly with higher risk or more invasive devices, even minor changes can create the need for a full chemical characterization study. Having an ongoing dialogue and a strong relationship with testing partners can help level-set expectations for testing timelines and planning needs.

    Special considerations for 3D printers
    The use of 3D printers is becoming more widespread as a potential solution to help fill the gaps manufacturers experience with production. However, safety standards for this method of production are unclear. In the past, regulators faced challenges in developing consistent standards for 3D-printed medical devices or components. Manufacturers advocating for the use of 3D printers should consult with their regulatory body to ensure patient safety and quality assurance.

    Without an exact blueprint to follow for 3D printing materials and the testing that follows, the process starts by taking steps such as selecting transparent material suppliers and gathering as much data on the materials as possible. Creating a paper trail helps build a solid foundation for reference during the risk analysis. Finally, this information can be useful to develop a testing plan customized to the risks at hand, as uniform testing is not yet an option. By working closely with a testing lab, compliance groups, and regulatory bodies, medical device manufacturers can ensure that everyone is on the same page and anticipate any potential setbacks.

    Selecting Partners
    The challenges manufacturers face in remaining streamlined and efficient apply to their partner organizations, too. Production partners should be selected carefully and thoughtfully. Companies engaging additional testing or manufacturing partners and/or working with regulatory agencies should start the process early, even if the product isn’t yet available, as shipping delays might occur.

    In a largely “work-from-home” world, many manufacturers have had to become more inventive in conducting quality audits. Virtual audits are now more commonplace. For larger companies, there may be options to leverage previously approved partners used in other divisions. Utilizing audits completed by another division within the company could abridge the necessary vetting procedures and save valuable time and money.

    Conversely, companies can also consider using current partners in new ways. For example, a manufacturer that relies on an outsourced testing lab for gathering biocompatibility data could get more mileage out of the partnership by also using the lab for an additional service like chemistry (if offered). With a previous facility audit already approved, this experience could lead to a more streamlined qualification process for other services or sites.

    When working with any partner, new or established, it’s essential to understand their functionality in response to global conditions and how that could impact projects. One area susceptible to increased activity is information technology (IT) infrastructures, which could be under strain as teams try to adequately support new working conditions. In regards to testing in areas like chemistry, if the investment in the IT supporting this function isn’t significant, data processing and results could face delays. Finding partners with proven quality and updated technology can help ensure timely project delivery.

    Understanding the Manufacturer’s Role
    Staying ahead of quality assurance risks may seem like a daunting task but in the long run, it can save time and possibly avoid regulatory setbacks or patient safety issues. Discovering the cause of complications and involving the right parties is the basis for successful management. Still, there are some steps that must be taken to help companies adhere to product development timelines.

    First, manufacturers should involve the procurement team in their development conversations, especially when discussing sourcing materials. Companies often won’t use a single source for all their materials and could be considering three or more vendors. The procurement team can help assess possible risks while evaluating the necessary capabilities in the production process.

    Next, gather all information including test reports, field reports and material information to perform a new risk assessment. Regulatory standards are continually evolving, and the testing performed on a device even 12 months prior may not be up to standards. If a company isn’t using comparable data during a risk analysis, it could be evaluating apples to oranges.

    Finally, taking note of process changes and their effectiveness is key to gaining the most value from potential change. Many in the industry are monitoring their responses to the current environment to inform future decisions. From discovering new capabilities with remote working, re-evaluating supply chains or navigating new partner auditing processes, there is potential to recognize opportunities for further efficiencies. Companies can take setbacks from recent events and use what they’ve learned to shape their business strategy going forward.

    Bringing medical devices to market and maintaining the compliance of existing devices is a time-consuming responsibility, even when everything goes according to plan. Fortunately, involving the right partners early in the process and throughout development can help close gaps and expand team knowledge. If medical device companies dedicate time to identifying obstacles and proactive planning, achieving the highest level of quality assurance can be much more attainable. 


    Sandi Schaible is the senior director of analytical chemistry and regulatory toxicology at WuXi AppTec Medical Device Testing, located in St. Paul, Minn., specializing in extractables and leachables studies. She is a U.S. delegate and international delegate for ISO 10993 part 18 in chemical characterization, and also a U.S. delegate for ISO 10993 part 13 and the particulates committee (TIR42).

    Peter Steen received his B.S. in chemistry and M.S in civil engineering from the University of Minnesota. His expertise includes chromatographic method development and validation, raw materials testing, medical device testing, and mass spectrometry. Since 2014 he’s worked in the area of extractables/leachables testing at WuXi AppTec Medical Device Testing and serves as a subject matter expert in gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS) analyses.
    Suggested For You
    Auriga Inc. Auriga Inc.
    WESTPAK, Inc. WESTPAK, Inc.
    BMP Medical - Delivering Custom Plastics Manufactured Solutions BMP Medical - Delivering Custom Plastics Manufactured Solutions
    Simbex Simbex
    DDL Inc. DDL Inc.
    High Tech Turning Co. Inc. High Tech Turning Co. Inc.
    Nissha Medical Technologies Nissha Medical Technologies
    Beaumont Beaumont
    sfm medical devices GmbH sfm medical devices GmbH
    IMA Automation North America IMA Automation North America
    Breakthrough Device Designation Granted for New Neuromodulation Platform Breakthrough Device Designation Granted for New Neuromodulation Platform
    Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    Accu-Tube Appoints Matthew Haddle as CEO Accu-Tube Appoints Matthew Haddle as CEO
    First CellFX Procedure Performed in Canada First CellFX Procedure Performed in Canada
    Turner Imaging Systems Announces International Expansion Turner Imaging Systems Announces International Expansion

    Related Buyers Guide Companies

    • Auriga Inc.

      ...
      Aleksandr Rodionov, Marketing manager 06.09.22

    • WESTPAK, Inc.

      WESTPAK, Inc.

      ...
      Tim Eells, WESTPAK, Inc. 03.04.22

    • BMP Medical - Delivering Custom Plastics Manufactured Solutions

      BMP Medical - Delivering Custom Plastics Manufactured Solutions

      Medical Contract Manufacturing, Design, Assembly & Packaging


    • Simbex

      ...
      Greg Lange, Chief Business Development Officer 11.15.21

    • DDL Inc.

      DDL Inc.

      DDL has been in medical device package, product and material testing industry for almost 20 years. We strive to offer the most effective business practices while employing a staff of technical experts.
      Chris Murphy, Marketing Manager 11.11.21

    Loading, Please Wait..

    Trending
    • Cardinal Health CEO Mike Kaufmann Steps Down
    • Medidata Unveils New Tech To Improve Clinical Trial Oversight
    • How To Overcome The Top 6 Medical Device Manufacturing Challenges
    • TruArc Expands Medical Portfolio With Acquisition Of Molded Devices Inc.
    • Chronic, Infectious Disease Prevalence To Benefit Vital Signs Monitoring Market
    Breaking News
    • BD Recalls Intraosseous Products Over Multiple Issues
    • Rapid Medical Expands U.S. Portfolio
    • MMS Holdings Partners With Lindsay Goldberg
    • ENDRA Life Sciences Issued 28th Patent
    • Levita Magnetics Closes $26M Series C
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Parylene Coatings for Medical Device Technologies
    • Nearshoring Trends in Medtech Manufacturing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    Valspar Reveals Fresh Lineup of New Shades in 2023 Colors of the Year
    Evonik Grows Strongly in 1H 2022
    PPG Chairman and CEO Joins Disability:IN Effort to Advance Disability Inclusion
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BD Recalls Intraosseous Products Over Multiple Issues
    Rapid Medical Expands U.S. Portfolio
    MMS Holdings Partners With Lindsay Goldberg
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Almac Invests $65M to Expand North American HQ
    Pace Appoints Nisheet Gupta as EVP and Chief Financial Officer
    West Pharmaceutical Makes Strategic Investment in Latch Medical
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Arkay Chairman Emeritus Howard Kaneff Has Died
    Nutricosmetics Market to Hit $13.7 Billion by 2030
    Estée Lauder Pledges 100% Electric Fleet of Vehicles by 2030
    Happi

    Latest Breaking News From Happi

    Odor Elimination with Prickly Pear Extract or Persimmon Juice
    Photocurable Resin for Nails and Artificial Nails
    Hair Product Patented by L’Oréal
    Ink World

    Latest Breaking News From Ink World

    Flexible Packaging Market Expected to Reach $102.8 Billion by 2031: AMR
    Evonik Enjoys 31% Growth in 1H 2022
    Sun Chemical Returns to Labelexpo Americas 2022
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Hybrid Software joins The Flexo Xperience Center
    Flexo Wash LLC and Mike Potter celebrate 20 years
    Colordyne hosts open house featuring hybrid print technology
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Focke & Co. to Host Destination: Your Hygiene Hub on August 31
    Exports Dominate Chinese Trade of Tissues, Hygiene Products and Wipes
    Freudenberg to Present Friction Inserts for Wind Energy
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Study Results Released for Abbott's Concussion Blood Test
    Bone Growth Stimulators Market to Top $3B by 2030
    Surgalign, RTI Settle Lawsuit Over OEM Biz Sale
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    eMagin Corporation Announces 2Q 2022 Results
    Zebra Technologies’ Emission Reduction Targets Validated by SBTi
    Identiv Delivers Impressive 41% Year-over-Year Growth in RFID Business

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login